Screening for Lung Cancer in India: Expert Opinion Statement.


Journal

The Journal of the Association of Physicians of India
ISSN: 0004-5772
Titre abrégé: J Assoc Physicians India
Pays: India
ID NLM: 7505585

Informations de publication

Date de publication:
May 2024
Historique:
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: ppublish

Résumé

Lung cancer (LC) has the highest rate of disability-adjusted life years (DALY) of all cancers in India. A large majority of patients with LC present with advanced disease, resulting in poor survival rates. Early diagnosis can improve survival outcomes as the patients can be treated with curative intent. The National Lung Screening Trial (NLST), in 53,454 persons at high risk for LC in the US, showed a 20% (95% confidence interval of 6.8-26.7;

Identifiants

pubmed: 38881114
doi: 10.59556/japi.72.0373
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1-e16

Informations de copyright

© Journal of the Association of Physicians of India 2024.

Auteurs

Agam Vora (A)

Medical Director, Department of Pulmonary Medicine, Vora Clinic, Mumbai, Maharashtra, India, Corresponding Author.

T Balamugesh (T)

Professor and Head, Department of Pulmonary Medicine, Christian Medical College, Vellore, Tamil Nadu, India.

Digambar Behera (D)

Director, Pulmonary Medicine, Fortis Health Care, Mohali, Punjab, India.

Prabhash Kumar (P)

Professor and Head, Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.

Mangesh Tiwaskar (M)

Director and Head, Department of Internal Medicine, Shilpa Medical Research Centre, Mumbai, Maharashtra, India.

Parthiv Mehta (P)

Director, Department of Pulmonary Medicine, Mehta Hospital Cardiopulmonary Care Centre, Ahmedabad, Gujarat, India.

Raja Dhar (R)

Director, Department of Pulmonology, C K Birla Group of Hospitals, Kolkata, West Bengal, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH